NCT05669365

Brief Summary

The Care Ecosystem is an accessible, remotely delivered team-based dementia care model, designed to add value for patients, providers and payers in complex organizational and reimbursement structures. Care is delivered via the phone and web by unlicensed Care Team Navigators, who are trained and supervised by a team of dementia specialists with nursing, social work, and pharmacy expertise. The evidence base to date suggests that the Care Ecosystem improves outcomes important to people with dementia, caregivers, and payers when delivered in a controlled research environment, including reduced emergency department visits, higher quality of life for patients, lower caregiver depression, and reduced potentially inappropriate medication use (Possin et al., 2019; Liu et al., 2022). The investigators propose a rapid pragmatic trial in 6 health systems currently offering the Care Ecosystem program in geographically and culturally diverse populations. The investigators will leverage technology, delivering care via the phone and web and using electronic health records to monitor quality improvements and evaluate outcomes while maximizing external validity. The investigators will evaluate the effectiveness of the Care Ecosystem on outcomes important to patients, caregivers, healthcare providers, and health systems during the pandemic. By evaluating the real-world effectiveness in diverse health systems that are already providing this model of care, this project will bridge the science-practice gap in dementia care during an unprecedented time of heightened strain on family caregivers, healthcare providers and health systems.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,227

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2023

Typical duration for not_applicable

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 19, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 30, 2022

Completed
18 days until next milestone

Study Start

First participant enrolled

January 17, 2023

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2025

Completed
Last Updated

September 2, 2025

Status Verified

August 1, 2025

Enrollment Period

2.6 years

First QC Date

December 19, 2022

Last Update Submit

August 29, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Dementia Management Quality Measurement Set

    The rate of completion of a 10-item, adapted Dementia Management Quality Measurement Set. This count variable has a range of 0 (no dementia quality care elements completed) to 10 (all dementia quality care elements completed).

    Baseline to 12 months

  • Change in emergency department (ED) visits

    Number of PWD ED visits, using claims and EHRs.

    Baseline to 12 months

  • Change in potentially inappropriate medications for dementia or cognitive impairment

    Number of high-risk medications used, operationalized using the 2019 Beers criteria, using medication lists from the EHR.

    Baseline to 12 months

  • Change in caregiver depression

    Caregiver depression will be measured by the 9-item Patient Health Questionnaire (PHQ-9), ranging from 0-27 points, with higher scores indicating more severe depression.

    Baseline to 12 months

Secondary Outcomes (6)

  • Change in PWD hospitalizations

    Baseline to 12 months

  • Change in PWD annual bed days

    Baseline to 12 months

  • Change in central nervous system (CNS) acting medications

    Baseline to 12 months

  • Change in caregiver burden

    Baseline to 12 months

  • Change in caregiver self-efficacy

    Baseline to 12 months

  • +1 more secondary outcomes

Other Outcomes (1)

  • Modifications of anti-dementia medications

    Baseline to 12 months

Study Arms (1)

Care Ecosystem

EXPERIMENTAL

Patient and caregiver dyads receive the Care Ecosystem intervention

Behavioral: Care Ecosystem

Interventions

Care EcosystemBEHAVIORAL

Applying the principles of person-and-family centered and collaborative care to dementia, the Care Ecosystem (CE) offers proactive, protocol-guided phone- and web-based caregiver support, guidance, and care coordination that extends the reach of dementia primary and specialty care. Care is delivered primarily via the phone and web by unlicensed Care Team Navigators (CTNs), who are trained and supervised by a team of dementia specialists with nursing, social work, and pharmacy expertise. Care Protocols guide proactive, quality care that is documented in the electronic health record (EHR). The CTN is an unlicensed, trained dementia care guide who served as the PWD's and caregiver's primary point of contact to the program under nurse supervision. Care team navigators respond to caregivers' immediate needs first, then screen for common problems and provide personalized support and standardized education using the care plan protocols.

Care Ecosystem

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18+
  • Provision of verbal consent (or surrogate consent), documented in REDCap, and assent
  • Willingness to enroll in the Care Ecosystem program
  • Lives in the community (i.e., not in an assisted living, board \& care, skilled nursing or memory care facility) at the time of enrollment
  • Have a dementia diagnosis documented in the EHR
  • Has had a visit with the referring provider in the last 12 months
  • Has a caregiver with a primary level of responsibility for the patient who is eligible and willing to participate
  • Age 18+
  • Provision of verbal consent, documented in REDCap
  • Has a primary level of responsibility for the care of a PWD-participant who is enrolling in the study
  • Willingness to enroll in the Care Ecosystem program and complete surveys

You may not qualify if:

  • PWD-participants for whom a substantial amount of the patient's healthcare utilization records cannot be accessed for research purposes by the study team. (see Note)
  • Is currently, or was ever enrolled, in the Care Ecosystem program.
  • Medical documentation indicates that the patient's dementia is a non-progressive type (e.g., due to a head injury or stroke, and not expected to progress).
  • Ochsner Health System Providence Health \& Services Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center HealthPartners Institute University of Colorado, Denver University of California, San Francisco

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

University of California, San Francisco

San Francisco, California, 94158, United States

Location

LA County Harbor-UCLA Medical Center

Torrance, California, 90502, United States

Location

University of Colorado Health

Denver, Colorado, 80209, United States

Location

Ochsner Medical Center

New Orleans, Louisiana, 70121, United States

Location

HealthPartners

Saint Paul, Minnesota, 55130, United States

Location

Providence Health

Portland, Oregon, 97213, United States

Location

Related Publications (4)

  • Peipert JD, Jennings LA, Hays RD, Wenger NS, Keeler E, Reuben DB. A Composite Measure of Caregiver Burden in Dementia: The Dementia Burden Scale-Caregiver. J Am Geriatr Soc. 2018 Sep;66(9):1785-1789. doi: 10.1111/jgs.15502. Epub 2018 Aug 10.

    PMID: 30094817BACKGROUND
  • Possin KL, Merrilees JJ, Dulaney S, Bonasera SJ, Chiong W, Lee K, Hooper SM, Allen IE, Braley T, Bernstein A, Rosa TD, Harrison K, Begert-Hellings H, Kornak J, Kahn JG, Naasan G, Lanata S, Clark AM, Chodos A, Gearhart R, Ritchie C, Miller BL. Effect of Collaborative Dementia Care via Telephone and Internet on Quality of Life, Caregiver Well-being, and Health Care Use: The Care Ecosystem Randomized Clinical Trial. JAMA Intern Med. 2019 Dec 1;179(12):1658-1667. doi: 10.1001/jamainternmed.2019.4101.

    PMID: 31566651BACKGROUND
  • Merrilees JJ, Bernstein A, Dulaney S, Heunis J, Walker R, Rah E, Choi J, Gawlas K, Carroll S, Ong P, Feuer J, Braley T, Clark AM, Lee K, Chiong W, Bonasera SJ, Miller BL, Possin KL. The Care Ecosystem: Promoting self-efficacy among dementia family caregivers. Dementia (London). 2020 Aug;19(6):1955-1973. doi: 10.1177/1471301218814121. Epub 2018 Nov 29.

    PMID: 30497302BACKGROUND
  • Liu AK, Possin KL, Cook KM, Lynch S, Dulaney S, Merrilees JJ, Braley T, Kiekhofer RE, Bonasera SJ, Allen IE, Chiong W, Clark AM, Feuer J, Ewalt J, Guterman EL, Gearhart R, Miller BL, Lee KP. Effect of collaborative dementia care on potentially inappropriate medication use: Outcomes from the Care Ecosystem randomized clinical trial. Alzheimers Dement. 2023 May;19(5):1865-1875. doi: 10.1002/alz.12808. Epub 2022 Nov 4.

    PMID: 36331050BACKGROUND

MeSH Terms

Conditions

DementiaDementia, VascularLewy Body DiseaseAlzheimer DiseaseFrontotemporal Dementia

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental DisordersCerebrovascular DisordersIntracranial ArteriosclerosisIntracranial Arterial DiseasesLeukoencephalopathiesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesParkinsonian DisordersBasal Ganglia DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesTauopathiesFrontotemporal Lobar DegenerationTDP-43 ProteinopathiesProteostasis DeficienciesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Katherine L Possin, PhD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 19, 2022

First Posted

December 30, 2022

Study Start

January 17, 2023

Primary Completion

August 15, 2025

Study Completion

August 15, 2025

Last Updated

September 2, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

Investigators will submit resource requests for archived data through a Qualtrics-based form, which will include a signed "Data Use Agreement". These will be reviewed monthly by the investigators. If a request is approved, the study staff will review the requested dataset to ensure it is de-identified and encrypted for transfer, along with a data dictionary.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Data requests will be accepted starting 12 months after study close with no end date.
Access Criteria
Access to trial individual participant data (IPD) can be requested by qualified researchers engaging in independent scientific research, and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing Agreement (DSA).
More information

Locations